Iloprost Inahalation Solution Suppliers & Bulk Manufacturers
Available Forms: Inhalation Solution (Nebulizer)
Available Strengths: 10 mcg/mL
Reference Brands: Ventavis®(EU & US)
Category:
Orphan Drugs
Iloprost inhalation solution is a prostacyclin analogue that dilates pulmonary blood vessels, reducing pulmonary arterial pressure. It inhibits platelet aggregation, preventing clots. Benefits include improved exercise capacity, symptom relief, and enhanced quality of life for PAH patients, especially in those with advanced disease requiring targeted inhalation therapy.
Product Description:
Iloprost inhalation solution, marketed as Ventavis®, is approved in the US and EU for pulmonary arterial hypertension (PAH). Regulatory dossiers include detailed clinical trials, manufacturing standards, and safety data submitted to FDA and EMA, supporting its approval. The inhalation therapy delivers prostacyclin directly to the lungs, improving exercise capacity and symptoms. The product is supplied in vials of 20 mcg/mL for nebulization, with dosing tailored to individual patient needs. For comprehensive insights on regulatory submissions, dossier requirements, and market approvals, visit PharmaTradz, your trusted source for pharmaceutical regulatory updates and industry insights.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing